Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COVID-19 Impact on Intravitreal Injections
NCT05494775Unknown
- Sponsor
- Benha University
- Start
- Feb 2019
- Primary completion
- Jun 2023
- Countries
- 1
01
Overview
Open-label trial in diabetic macular edema (DME), exudative macular degeneration, retinal vein occlusion (RVO) and 2 more (4 arms), sponsored by Benha University. Primary endpoint: Visual acuity. Status: unknown.
02
Conditions
diabetic macular edema (DME)exudative macular degenerationretinal vein occlusion (RVO)myopic choroidal neovascularization (mCNV)proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT05494775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05494775.